This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
07 Aug 2015 | Asia Pacific
Japan Contract Research Organization Market
Aging Population and Liberal Regulations will Propel Clinical Trial Growth
This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...
$1,500.00 -
07 Aug 2015 | Global
Indian Contract Research Organization (CRO) Market
The Evolving Regulatory Scenario is Likely to Boost Market Growth
This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...
$1,500.00 -
03 Aug 2015 | Europe
The South Korean Contract Research Organization Market
Government Initiatives Offer Powerful Boost to the Clinical Trials Industry
Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...
$1,500.00 -
03 Aug 2015 | Africa
China Contract Research Organisation Market
Exploring the Market Landscape and Future Opportunities
The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...
$1,500.00 -
This issue profiles a novel blood pumping device to aid heart failure patients, an ultrasound diagnostic tool for bone strength assessment, and a wearable maternal-fetal monitor to improve prenatal health.
$950.00 -
This issue profiles development of a triboelectric nanogenerator, biomechanical energy harvesting with piezoelectric nanogenerators, and chemotherapy enabled by nanoparticles treats cancer stem-like cells.
$250.00 -
This issue profiles a high-priced hepatitis c drug that results in development of generic products, a rapid antigen test for Ebola, and focused antiviral clinical programs for infectious diseases.
$250.00 -
This issue profiles an imaging app for ultrasound, a compatible leads for MRI systems, and innovative contrast agents for preclinical imaging.
$950.00 -
This issue profiles a drug for oculopharyngeal muscular dystrophy treatment that receives orphan drug designation; non-viral CFTR-based gene therapy for cystic fibrosis patients, a breast cancer diagnostic test in Europe.
$250.00 -
This issue profiles a novel microchip-enabled drug-delivery system, a technology for reducing diesel engine emissions, and head-up displays that get transformed into consumer wearables.
$250.00
